AVM Biotechnology Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Financing Rounds
  • 18

AVM Biotechnology General Information

Description

Developer of small molecule therapeutics designed to treat blood cancers and solid tumors through targeted oncology treatment. The company offers a clinical-stage therapeutic candidate with pan-cancer activity, low toxicity characteristics, and expanded access treatment applications, enabling cancer patients and healthcare providers to access lower side-effect treatment options for a broad range of cancer indications.

Contact Information

Formerly Known As
Ave Maria Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 1700 7th Avenue
  • Suite 2100
  • Seattle, WA 98109
  • United States
+1 (206)
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 1700 7th Avenue
  • Suite 2100
  • Seattle, WA 98109
  • United States
+1 (206)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AVM Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AVM Biotechnology‘s full profile, request access.

Request a free trial

AVM Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small molecule therapeutics designed to treat blood cancers and solid tumors through targeted oncology trea
Drug Discovery
Seattle, WA
6 As of 2026

Boston, MA
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AVM Biotechnology Competitors (37)

One of AVM Biotechnology’s 37 competitors is Aura Biosciences, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aura Biosciences Formerly VC-backed Boston, MA
Voyager Therapeutics Formerly VC-backed Lexington, MA
Mesoblast Corporation Melbourne, Australia
BioCardia Formerly VC-backed Sunnyvale, CA
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
You’re viewing 5 of 37 competitors. Get the full list »

AVM Biotechnology Patents

AVM Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3229529-A1 Lymphocyte population and methods for producing same Pending 01-Sep-2021
EP-4395784-A1 Lymphocyte population and methods for producing same Pending 01-Sep-2021
US-20240358829-A1 Lymphocyte population and methods for producing same Pending 01-Sep-2021
WO-2023034377-A1 Lymphocyte population and methods for producing same Inactive 01-Sep-2021
AU-2020451285-A1 Methods of treatment using icam-modulating agents Inactive 01-Jun-2020 A61K31/573
To view AVM Biotechnology’s complete patent history, request access »

AVM Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AVM Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AVM Biotechnology‘s full profile, request access.

Request a free trial

AVM Biotechnology FAQs

  • When was AVM Biotechnology founded?

    AVM Biotechnology was founded in 2008.

  • Where is AVM Biotechnology headquartered?

    AVM Biotechnology is headquartered in Seattle, WA.

  • What is the size of AVM Biotechnology?

    AVM Biotechnology has 6 total employees.

  • What industry is AVM Biotechnology in?

    AVM Biotechnology’s primary industry is Drug Discovery.

  • Is AVM Biotechnology a private or public company?

    AVM Biotechnology is a Private company.

  • What is the current valuation of AVM Biotechnology?

    The current valuation of AVM Biotechnology is .

  • What is AVM Biotechnology’s current revenue?

    The current revenue for AVM Biotechnology is .

  • How much funding has AVM Biotechnology raised over time?

    AVM Biotechnology has raised $16.1M.

  • Who are AVM Biotechnology’s investors?

    Life Science Washington Institute, Small Business Innovation Research and Small Business Technology Transfer Programs, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institutes of Health are 5 of 7 investors who have invested in AVM Biotechnology.

  • Who are AVM Biotechnology’s competitors?

    Aura Biosciences, Voyager Therapeutics, Mesoblast, BioCardia, and Cellaion are some of the 37 competitors of AVM Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process